Nancy Doyle

Nancy Doyle

Scientific Advisor

Nancy Doyle was hired at Charles River as an animal health technician in Musculoskeletal research in 1996, while she was completing her bachelor degree in biology. Once she graduated from the University of Quebec in Montreal (UQAM) in 1998, she got promoted as Study Director within the Musculoskeletal group.

During the 20 years she was Study Director, she was responsible in the design and execution of studies with bone endpoints in most species and route of administration from juvenile to geriatric populations. She has experience in preclinical imaging, bone biomarkers, biomechanics in musculoskeletal research and toxicology and with a wide range of orthopedic and disease models (ex: osteotomy, critical size defect, OVX, ORX, CIA, TPTx) and medical device in the different species.

She joined the Scientific Advisor Services group of Charles River in 2018 where her role was to guide clients designing their preclinical program to address regulatory and scientific questions for different type of product including drugs, biologics and medical devices.

She is now a scientific advisor at AccelLAB, a Charles River Company, where she continues providing advice to clients but focusing on medical devices. She has co-authored several research papers in peer reviewed scientific journals related to musculoskeletal research, including cartilage research and Toxicology and co-authored a chapter to a book on bone toxicology.

LinkedIn Profile